{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001838","form_type":"8-K","ticker":null,"cik":"0001708331","company_name":"Virpax Pharmaceuticals, Inc.","filed_at":"2024-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.297996+00:00","generated_at":"2026-05-29T21:59:41.921558+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Virpax appoints Usama Chaudhry as CFO under independent contractor agreement","bullets":["Appointment effective November 18, 2024; Chaudhry to oversee financial reporting, budgeting, compliance.","Annual fee of $180,000 payable in monthly installments; reasonable pre-approved expenses reimbursed.","Chaudhry holds a Bachelor of Commerce in accounting from University of Northern British Columbia.","Agreement is with Chaudhry U Consulting Inc.; Chaudhry remains independent contractor.","Agreement includes 12-month post-termination non-compete and non-solicitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001838","json":"https://secwatch.observer/filing/0001731122-24-001838.json","markdown":"https://secwatch.observer/filing/0001731122-24-001838.md","text":"https://secwatch.observer/filing/0001731122-24-001838.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001838/0001731122-24-001838-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001838/e6160_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:59:41.921558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ccb87dc9ce","claim":"Usama Chaudhry was appointed as Chief Financial Officer at Virpax Pharmaceuticals, Inc..","evidence_excerpt":"On November 18, 2024, Virpax Pharmaceuticals, Inc. (the “Company”) appointed Mr. Usama Chaudhry as Chief Financial Officer of the Company under an Independent Contractor Agreement (the “Agreement”) with Chaudhry U Consulting Inc., a Canadian corporation represented by Mr. Chaudhry.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001838/0001731122-24-001838-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}